“The Father of Cannabis Research”, Raphael Mechoulam, is being honored by The Arcview Group with a Lifetime Achievement Award. There will also be a $10,000 research grant in their first annual cannabis awards presentation at the Arcview Investor Forum: The Evolution of Cannabis 2020. This awards presentation will take place in New York on Thursday, October 3, 2019. Mechoulam’s contribution to the understanding and utilization of cannabis for positive benefits is unmatched. He is being recognized for his cutting-edge cannabis research and breakthrough discovery of THC.
Arcview will be preserving and continuing the invaluable work of Mechoulam by naming future recipients of this award the “Arcview Raphael Mechoulam Lifetime Acheivement Award”.
The Arcview Group CEO and co-founder, Troy Dayton, stated that “Cannabis research has never been more critical to the future of our industry, especially as the federal government begins processing dozens of pending applications for the steps necessary to improve access to marijuana research”.
As Raphael is the first person to synthesize THC, identify the endocannabinoid system, and illustrate the medicinal properties of cannabis, no one is more deserving for the award.
The Arcview Investor Forum will bring together the biggest fund managers, CEOs of the largest cannabis companies, and key investors in the industry. Arcview’s members have also selected seven cannabis companies that will present to investors in a ‘Shark Tank’ style format. Space to attend the forum is extremely limited, at this time. Accredited investors interested in attending the forum. A special “Preview Day” will launch for the first time ever on Wednesday, October 2, 2019. If you wish to be a part of this event, you can register at http://events.arcviewgroup.com/.